Stay updated on CAB-AXL-ADC Study in NSCLC Clinical Trial
Sign up to get notified when there's something new on the CAB-AXL-ADC Study in NSCLC Clinical Trial page.

Latest updates to the CAB-AXL-ADC Study in NSCLC Clinical Trial page
- Check5 days agoChange DetectedRevision updated from v3.4.2 to v3.4.3.SummaryDifference0.0%

- Check12 days agoNo Change Detected
- Check19 days agoNo Change Detected
- Check33 days agoChange DetectedRevision: v3.4.2 added. The government funding notice and Revision: v3.4.1 were removed.SummaryDifference0.3%

- Check41 days agoChange DetectedAdded a notice about government funding impacting information timeliness. Updated the site revision from v3.4.0 to v3.4.1.SummaryDifference0.3%

- Check48 days agoChange DetectedThe page includes a glossary option and adds QC metadata (Last Update Submitted that Met QC Criteria and Last Update Posted), No FEAR Act Data, and Revision: v3.4.0, while removing Last Update Submitted that met QC Criteria, Last Update Posted (Estimated), No FEAR Act data, and Revision: v3.3.4. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check62 days agoChange DetectedRevision: v3.3.4 replaces v3.3.3 on the page; no visible changes to core study content, eligibility criteria, or study details. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check84 days agoChange DetectedThe Locations section was expanded to include new sites across multiple U.S. states and international regions (e.g., Liguria, Andalusia, Catalonia, Madrid, Navarre). The update is labeled Revision: v3.3.3.SummaryDifference2%

Stay in the know with updates to CAB-AXL-ADC Study in NSCLC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the CAB-AXL-ADC Study in NSCLC Clinical Trial page.